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ABSTRACT
According to the World Health Organization (WHO), government plays a crucial role in providing quality life for its 
citizens through good health system. There has been less attention given in analysing the relationship between government 
expenditure, governance and health outcomes particularly in developing countries. This paper aims to study the impact 
of public health expenditure and governance on health outcomes in Malaysia. An Autoregressive Distributed Lag (ARDL) 
cointegration framework has been used to analyse data from 1984 to 2009. The results based on the bounds testing 
procedure show that a stable, long-run relationship exists between health outcomes and their determinants; namely 
income level, public health expenditure, corruption and government stability. The results also reveal that public health 
expenditure and corruption affect long- and short run health outcomes in Malaysia. The findings are important to the 
policy makers in making decisions to improve the citizens’ quality of life. We suggest the Ministry of Health of Malaysia 
to conduct more consultations with other ministries and other stakeholders in health services as to identify the needs 
and emphasize on the importance of health program to the society. At the same time, attention should be given to reduce 
or eliminate the corruption rate as it has adverse effects on the country.
Keywords: Governance; corruption; health; public health expenditure 
ABSTRAK
Berdasarkan Pertubuhan Kesihatan Sedunia, kerajaan memainkan peranan yang penting bagi meningkatkan kualiti 
hidup setiap warganegara melalui sistem kesihatan yang baik. Berdasarkan kajian sebelum ini, kajian mengenai kesan 
perbelanjaan kerajaan dan urus tadbir ke atas hasil kesihatan terutama kajian di negara-negara membangun masih 
terhad. Kertas kerja ini bertujuan untuk mengkaji kesan perbelanjaan kesihatan awam dan urus tadbir ke atas natijah 
kesihatan di Malaysia. Rangka kerja Autoregressive Distributed Lag (ARDL) cointegration telah digunakan untuk 
menganalisis data dari tahun 1984 hingga 2009. Keputusan daripada prosedur ujian sempadan menunjukkan wujud 
hubungan jangka panjang yang stabil antara natijah kesihatan dan penentu-penentunya iaitu tingkat pendapatan, 
perbelanjaan kesihatan awam, rasuah dan kestabilan kerajaan. Keputusan juga menunjukkan bahawa perbelanjaan 
kesihatan awam dan rasuah mempunyai kesan jangka panjang dan jangka pendek ke atas hasil kesihatan di Malaysia. 
Penemuan ini penting kepada pembuat dasar dalam menentukan peruntukan yang sesuai bagi meningkatkan kualiti 
hidup orang ramai. Pada masa yang sama, perhatian juga perlu diberikan untuk mengurangkan atau menghapuskan 
kadar rasuah dalam negara berikutan kesan buruk terhadap negara dan orang ramai.
Kata kunci: Tadbir urus; kesihatan; perbelanjaan kesihatan awam; rasuah 
INTRODUCTION
According to the World Health Organization (WHO), a 
health system in every country comprises all organizations, 
institutions and resources that are devoted in producing 
health actions. A health action is defined as any effort, 
whether in personal health care, public health services 
or through intersectoral initiatives, in which its primary 
purpose is to promote, restore, maintain or improve 
health.1 The concept of health system as defined by the 
WHO shows that government in every country plays a 
vital role in ensuring the country’s health system achieves 
the required standard which includes providing better 
quality of life for the citizen. The link between public 
spending and development outcomes (economy or social 
outcomes) has been debated by many researchers such as 
Barro (1990), Ram (1986) and Ghali (1998) who discuss 
the relationship between government expenditure and 
economic outcome; meanwhile, Filmer and Pritchett 
(1999), Kim and Lane (2013) and Craigwell et al. 
(2012) focus on the social outcome. The most important 
discussion is how public spending may, in practice, 
be severed when there is no incentive mechanism in 
the public sector to use available funds for productive 
purposes. Recently, both economists and researchers 
have raised their concerns regarding the concept of 
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governance. Good governance will promote economic 
growth and greater economic productivity. However, 
increased public spending may not improve development 
outcomes as a result of ineffi ciency in public expenditure 
and governance. Consequently, public spending leads 
to crowd out private sector provision in health care. 
Furthermore, the infrastructure needed to access health 
care may not exist, rendering the increased health care 
spending ineffective. 
The Malaysian health system has been developed 
since its independence from the British in 1957, and is 
heavily infl uenced by the UK health system. The public 
sector health services are centrally administered by the 
Ministry of Health (MOH) through its central, state and 
district offi ces. The MOH emphasizes on the promotion of 
health and the provision of health care that is equitable, 
effective, effi cient and technologically appropriate. In 
terms of health status, Malaysia has made great gain in 
life expectancy for its people; an increase between 1970 
and 2008 for women from 65.6 to 76.4 years, and men 
from 61.6 to 71.6 years (Jaafar et al. 2013). Malaysia 
is also undergoing an epidemiological transition with 
causes of mortality shifting from communicable to non-
communicable diseases such as heart and lungs diseases 
(Jaafar et al. 2013). It indicates the new challenges facing 
the government of Malaysia in providing good services 
and facilities to its people.
Public spending particularly in health sector varies 
widely among countries. Some governments (particularly 
in less-developed countries) spend less than 1 percent 
of their Gross Domestic Product (GDP) on this sector 
(Rajkumar & Swaroop 2008), while in developed 
countries such as the United States, the government 
spends more than 10 percent of GDP on health care 
services (see Figure 1). Based on the data from the WHO, 
Malaysia spent a relatively low total health expenditure of 
3.47 percent of GDP in 2008. This expenditure increases 
gradually from year to year such as in year 2013, the 
total health expenditure was 4.03 percent of GDP. 
However, this percentage is relatively low if compared 
to developed countries such as the United States, United 
Kingdom and Japan. The trend of the total expenditure 
in Malaysia is quite similar to neighbouring countries 
such as Thailand and Philippines, while Indonesia’s 
percentage is the lowest. Figure 1 exhibits the total 
health expenditure in Malaysia and the comparison 
between several countries (developed and developing 
countries). On the other hand, the International Country 
Risk Guide reports that the corruption index in Malaysia 
is decreasing. For example, in 1990, the corruption index 
was 4, but in 2009 this index decreased to 2.5. The 
highest number of points indicates the lowest corruption 
level and the lowest number (0) indicates the highest 
corruption level. Corruption distorts the economic and 
fi nancial environment of a country, and leads to negative 
impact on social outcome. 
Based on this fact, this paper examines the effi cacy 
of government and the quality of institutions on the 
health outcomes in Malaysia. Besides, the motivation 
of this study is also derived from the lack of studies 
that focus on social outcome side. Most of the studies 
had concentrated on economics outcomes particularly 
on economic growth in developed countries. This paper 
examines the importance of government expenditure 
particularly health expenditure on health outcomes in 
Malaysia as one of developing countries. Interestingly, 
this study also takes into account the role of governance 
in affecting the health status of this country. Specifi cally, 
this paper analyses the long term relationships between 
public expenditure, institutions and health status in 
Malaysia. In addition, the paper aims to identify the 
short term relationship among variables. 
FIGURE 1. Health Expenditure among Selected Countries
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This paper contributes to the existing work in this area 
particularly in Malaysia. Previous studies such as Filmer 
and Pritchet (1999), Kneller et al. (1999) and Rajkumar 
and Swaroop (2008) had focused on either developed 
countries or using cross sectional data approach. 
There are limited studies that examine the relationship 
between health spending, governance and health status 
in developing countries, particularly Malaysia. Some 
of the studies have examined the impact of government 
expenditure on economic growth of Malaysia (e.g., 
Sinha 1998; Samudram et al. 2009; Tang 2009). Thus, 
this paper contributes to the existing literature in two 
ways. First, this study will extend the existing literature 
by focusing on the issue of public health expenditure and 
health outcomes in Malaysia. This paper also analyses the 
issue of governance namely corruption and government 
stability. This paper differs from previous studies as 
time series data instead of cross sectional approach is 
used. Second, this paper uses an econometric technique 
namely the Autoregressive Distributed Lagged (ARDL) 
testing procedure proposed by Pesaran et al. (2001). 
The method is sufficient in dealing with a short sample 
size and it allows a mixture of time series variables of 
I(0) and I(1) to be collectively estimated. This study 
will shed some light on the importance of public health 
expenditure and institutions in affecting health status for 
a small developing country.
The remainder of this paper is organized as follows: 
in Section 2 provides a brief review of the previous 
studies in this topic. Section 3 discusses the methodology, 
while Sections 4 and 5 discuss the findings and offer 
concluding remarks, respectively. 
LITERATURE REVIEW
There are substantial studies on the issue of government 
spending and its outcomes. The most important studies 
are those which examine the relationship between 
government spending and economic outcome such 
as economic growth. Previous studies such as Barro 
(1990), Dar and AmirKhalkhali (2002), Ghali (1998), 
Guseh (1997), Kneller et al. (1999), Levine and Renelt 
(1992) and Ram (1986) had focused on this issue. Some 
of these studies reported that government spending has 
a positive relationship with economic growth and some 
studies offered contradictory findings. Interestingly, 
some researchers have argued that there is a non-linear 
relationship between government expenditure and 
economic growth. 
On the other hand, there are studies that focus 
on the effects of government spending and social 
outcomes; education and health (Baldacci 2003; Filmer 
and Pritchett 1999; Kim and Lane 2013; Craigwell 
et al. 2012). According to Filmer and Pritchett (1999), 
in 1995 over nine million children, under five years, 
in developing countries died of avoidable deaths.2 It 
shows the vital role of the government in providing and 
maintaining good health in the country. Kim and Lane 
(2013) empirically analysed the relationship between 
public health expenditure and national health outcomes 
among developed countries. The result shows that there 
is a negative relationship between government health 
expenditure and infant mortality rate, and a positive 
relationship between government health expenditure 
and life expectancy at birth. Craigwell et al. (2012) 
assessed the efficacy of public spending on health care 
and education in 19 Caribbean countries and revealed 
that health expenditure has a significant positive effect 
on health status. Filmer and Pritchett (1999) found 
weak link between public spending and social outcome. 
However, it is difficult to draw policy conclusion from 
cross country data due to policy recommendations that are 
dependent upon a country’s specific situation. In addition, 
Kefeli and Zaidi (2014) studied the causal relationship 
between health and economic development for selected 
OIC countries (high income countries).
The link between public expenditure and health 
status has been described by researchers. For example, 
Rajkumar and Swaroop (2008) argued that there are 
two concepts to explain the low or negligible impact 
of public spending on development outcomes. First, 
it is argued that the link between public spending and 
development outcomes could be severed because an 
increase in public provision could lead to the substitution 
of private sector provision. Second, the ineffectiveness 
of public expenditure includes poor targeting and/or 
institutional inefficiencies such as leakage in public 
spending and weak institutional capacity also affects 
development outcomes negatively. In addition, Filmer 
and Pritchett (1999) explained that the three components 
of public health expenditure, namely health production 
function, net public sector impact, and public sector 
efficacy are important in achieving better health status. 
The main focus in health production function is the cost 
effectiveness of public spending. A second component is 
the net impact of public sector supply. In this component, 
it emphasizes on the role of government to supplement, 
not replacing the market with low cost services. The 
third component focuses on public sector efficacy and 
emphasizes on improving the operational performance 
of public sector health care providers. These three 
components are depicted in Figure 2 which shows the 
government’s vital role in supporting the provision for 
better health. 
Recent studies have begun to examine the importance 
of governance and institutional quality on development 
outcomes such as economic growth, foreign direct 
investment, public investment and social infrastructure. 
Rajkumar and Swaroop (2008) discussed the relationship 
between a variety of governance indicators and 
development outcomes from previous studies. According 
to the World Bank, good governance is characterized by 
predictable, open, and enlightened policy making (that 
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is, transparent processes); a bureaucracy imbued with a 
professional attitude; an executive arm of government 
accountable for its actions; and a strong civil society 
participating in public affairs; and all behaving under the 
rule of law. Good quality of governance and institutions 
will contribute to greater productivity in the economy 
and affect social outcomes as well. For example, 
Acemoglu et al. (2005), Acemoglu and Robinson 
(2010) and Mo (2001) explained the importance of 
institutions in promoting long run economic growth. 
Besides, Kaufmann et al. (1999) showed that governance 
indicators have a strong direct negative impact on infant 
mortality. Azfar and Gurgur (2005) examined the effect of 
corruption on outcomes in the Philippines and discovered 
that corruption negatively impact health outcomes. 
Interestingly, studies have been done by focusing on 
the integrated issue of public spending, governance and 
outcomes either in economic growth or social outcomes. 
Rajkumar and Swaroop (2008) examined the links 
between public spending, governance, and outcomes 
for 91 developed and developing countries. The result 
indicates that public spending on health care alone 
does not guarantee improved social outcomes; instead, 
quality governance tools such as well-functioning budget 
formulation, execution and monitoring are essential in 
producing a better health position.
In Malaysia, the study on the issue of health system 
is growing steadily. Kefeli and Jones (2012) examined 
moral hazard and the impact of private health insurance 
on the utilisation of health care. In addition, Kefeli and 
Zaidi (2013) examined the differences in the utilisation 
of health services among the elderly. Yu et al. (2008) 
comprehensively assessed the equity of health care 
fi nancing. Five fi nancing sources were studied and they 
are: direct taxes, indirect taxes, contributions to Employee 
Provident Fund and Social Security Organization, 
private insurance and out-of-pocket payments. These 
three studies use household surveys data to achieve their 
objectives. At macro level, Sinha (1998) studied the 
impact of government expenditure on economic outcome 
(economic growth) instead of social outcomes. Based on 
the above discussion, this paper contributes to the existing 
literature particularly in the case of Malaysia by using 
aggregate data. Interestingly, this paper focuses on the 
FIGURE 2. Public Spending for Better Health (Filmer and Pritchett (1999))
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issue of governance quality and its impact on health status 
in developing countries. While many studies have looked 
at the relationships between government expenditure, 
governance and health outcome using cross sectional 
data, there are limited number of studies that examine 
these relationships at the macro level using time series 
data especially in developing countries. Furthermore, 
policy formulation especially in increasing standard of 
living in developing countries can be strengthened by 
utilizing the findings from this study. Thus, this study is 
conducted to test the relationship between government 
spending, governance and health outcomes using time 
series data. 
METHODOLOGY
DATA
Due to the issue of data unavailability (governance 
data), this paper uses the dataset that has been collected 
annually starting from 1984 to 2009. There are two data 
sources. First, the data for national income (GDP), public 
health expenditure, total population, life expectancy, 
infant mortality, under-five mortality were collected 
from the Department of Statistics of Malaysia. Second, 
the data for corruption and government stability were 
collected from the International Country Risk Guide 
(ICRG). The corruption data are scaled from zero to six, 
while government stability data are scaled from zero 
to twelve; whereby higher values show better quality, 
and vice versa. Based on the ICRG, government stability 
has three subcomponents; namely government unity, 
legislative strength and popular support. The risk rating 
assigned is the sum of these three components, each with 
a maximum score of four points, and a minimum score of 
0 point. However, the ICRG does not give specific method 
to calculate the indices in assessing the quality of these 
subcomponents of institutions. Health outcomes, on 
the other hand, will be measured using three indicators 
namely life expectancy, infant mortality and under-five 
mortality. 
The inclusion of income in the model estimation will 
indicate the importance of income in improving health 
status through a variety of indirect channels, for instance 
providing better housing, sanitation and nutrition to the 
people in the country. In other words, higher income 
countries have the capability to invest more in health 
care services, and educate their people to live in healthy 
environment. As a result, health status and the quality of 
life can be improved. Thus, in this paper, it is expected 
that income level will improve national health status. As 
mentioned earlier, health outcomes will be measured by 
three indicators; therefore, there is a positive relationship 
between income level and life expectancy, a negative 
relationship between income level and infant mortality 
as well as under-five mortality. Besides, government 
spending (specifically public health expenditure) has a 
positive relationship with life expectancy, and a negative 
relationship with infant mortality and under-five mortality. 
The relationship between government spending and infant 
mortality is negative which reflects the efficacy of public 
spending in improving health status. This relationship 
has been confirmed by previous studies such as in 
Filmer and Pritchett (1999) and Rajkumar and Swaroop 
(2008). Corruption, on the other hand, is expected to 
have a negative relationship with life expectancy and 
a positive relationship with infant mortality and under-
five mortality. Government stability is expected to have 
a positive effect on life expectancy and a negative effect 
on infant mortality and under-five mortality.
ESTIMATION PROCEDURE
This study has employed the ARDL bounds test proposed 
by Pesaran and Shin (1995) and Pesaran et al. (2001) 
to investigate the relationships between health status, 
government spending and governance in Malaysia. The 
most important advantage of the bound test procedure is 
that it is applicable irrespective of whether the model’s 
regressors are purely I(0), purely I(1) or cointegrated. 
In other words, it does not require the pre-testing of the 
variables included in the model for unit roots, unlike other 
techniques such as the Johansen and Juselius’ (1990) 
approach. Another important advantage of the bound 
test procedure is that estimation is possible even when 
the explanatory variables are endogenous.
There are two steps in estimating the model. First, we 
did the estimation by using the bound test procedure to 
test for the existence of a long run relationship in levels 
among the variables. Next, we estimate the parameters 
of the long run relationship and the associated short run 
dynamic error correction model using the autoregressive 
distributed lag (ARDL) approach as proposed by Pesaran 
and Shin (1995) and Pesaran et al. (2001).
Based on Rajkumar and Swaroop’s (2008) model 
specification, the ARDL model in this study can be written 
as follows:
∆HOt = a0 + β1HOt–1 + β2GDPCt–1 + β3PHE 
 + β4CRPt–1 + β5GSTt–1 + ∑pi=1δ1∆HOt–i 
 + ∑qi=0δ2∆GDPCt–i + ∑ri=0δ3∆PHEt–i 
 + ∑si=0δ4∆CRPt–i  + ∑ti=10∆GSTt–i + εt (1)
In equation (1), HO indicates health outcomes. In 
this study, three indicators will be used to measure the 
health outcomes in Malaysia; namely infant mortality 
(IM), under-five mortality (UFM) and life expectancy 
(LFE). GDPC is Gross Domestic Product (GDP) per capita 
and it has been used to measure aggregate income level 
of a country. PHE is public health expenditure that has 
been measured by the share of public health to GDP, 
CRP represents index of corruption, while GST refers to 
government stability index. All variables are in natural 
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logarithm except the CRP and GST. There are two models 
that will be estimated in this paper. The first model will 
exclude the variable GST, while the second will estimate 
the model specification as shown in equation (1).
The null hypothesis of the non-existence of a long-
run relationship is H0:β1 = β2 = β3 = β4 = β5 = 0 against 
H1:β1 ≠ 0, β2 ≠ 0, β3 ≠ 0, β4 ≠ 0, β5 ≠ 0.The critical value 
bounds of the F-statistics are sensitive to the number of 
regressors (k), and are tabulated in Pesaran et al. (2001). 
Besides, Narayan (2005) also provides the critical values 
that account for small sample sizes. In this paper, we use 
the table provided by Pesaran et al. (2001). Two sets of 
critical values are provided. The upper bound assumes 
that all the variables in the ARDL model are I(1), while 
the lower bound assumes all variables to be I(0).The 
null hypothesis of no cointegration among variables can 
be rejected if the computed F-statistics is higher than 
the upper bound of the critical values. In contrast, if the 
computed F-statistics falls below the lower bound, then 
the null hypothesis cannot be rejected and there is no 
long run relationship among variables. Nevertheless, if 
the F-statistic falls within the critical value band, a unit 
root test of stationarity is needed to authenticate the order 
of integration of respective variables.
Once a cointegrating relationship is established, the 
cointegrating vector can be estimated using the ARDL 
model. The conditional ARDL(p, q, r, s, t) long-run model 
of the determinants of the HSt can be estimated as below:
HOt = a0 + ∑
p
i=1
β1HOt–i + ∑
q
i=1
β2GDPCt–i 
 + ∑ri=0β3PHEt–i + ∑si=0β4CRPt–i 
 + ∑ti=0β5GSTt–i + εt (2)
Finally, we estimate the short-run dynamic parameters 
by estimating an error correction model  (ECM) associated 
with the long run estimates. The specification is shown 
as follows:
∆HOt = ϑ0 + γ3ECMt–1 + ∑
p
i=1
Ø1∆HOt–i  
 + ∑
q
i=0
Ø2∆GDPCt–i + ∑
r
i=0
Ø3∆PHEt–i 
 + ∑si=0Ø4∆CRPt–i + ∑ti=0∆5GSTt–i + εt (3)
Where, Ø1, Ø2, Ø3, Ø4, and Ø5 are the short-run 
dynamic coefficients of the model’s convergence to 
equilibrium, and γ is the speed of adjustment. The focus 
of this study is on the relationship between public health 
expenditure, corruption and health status in Malaysia.
FINDINGS AND DISCUSSIONS
In this section, we report the results that have been 
estimated empirically using the ARDL model. The method 
is adequate and sufficient to deal with a short sample 
size, and allows a mixture of time series variables of I(0) 
and I(1) to be collectively estimated. In other words, the 
ARDL model does not require pre-testing for unit roots. 
For this reason, we proceed to report the results for the 
long run relationship among variables as discussed in 
detailed below. 
Table 1 presents the results of testing the existence 
of long run relationship between health status and public 
health and governance in Malaysia. There are two models 
that have been estimated for bound cointegration test. 
The optimum lag length two has been chosen based 
on Aikaike Information Criteria (AIC). The first model 
has three explanatory variables namely GDPC, PHE and 
CRP, while in the second model, we added an additional 
explanatory variable namely GST. Three indicators for 
health status have been used namely under-5 mortality, 
infant mortality and life expectancy. Based on the results, 
it can be seen that the null hypothesis of no relationship 
among variables is rejected at 5 percent significance level 
for model 1 when the LFE has been used as dependent 
variable. However, the null hypothesis is not rejected 
when the dependent variables are infant mortality and 
under-5 mortality. Similar results are obtained in model 2. 
The null hypothesis is only rejected when the dependent 
variable is life expectancy at 1 percent significance level. 
The computed F-statistics of 5.4578 and 11.0281 are 
greater than the upper bound value of 5.018 and 7.063 for 
both models, respectively. This indicates that there is a 
long-run relationship among variables. Next, we proceed 
to estimate the long run model of the determinants of 
TABLE 1. ARDL Cointegration Tests Results
Dependent variable Independent variable Lag F-statistic
Under 5 mortality
(Model 1)
GDPC, PHE, CRP 2
1.9224
Infant Mortality 1.6077
Life Expectancy 5.4578**
Under 5 mortality
(Model 2)
GDPC, PHE, CRP, GST 2
1.0862
Infant Mortality 0.6567 
Life Expectancy 11.0281*
Note: Lower and Upper Bound Critical Values
 10% 5% 1%
 [3.008 4.150] [3.710 5.018] [5.333 7.063]
 (*) and (**) indicate significant at 1% and 5% significance level respectively.
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health status in Malaysia by using life expectancy as a 
dependent variable in both models. The estimation results 
are reported in Table 2.
Next, Table 2 reports the results for the level long 
run parameter estimates of the model. The ARDL model 
(1,2,2,0) and model (1,2,1,0,1) as selected by the AIC and 
their asymptotic standard errors are shown in Table 2. For 
model 1, the results depict that all the coefficients are 
statistically significant at least at 5 percent significance 
level; while for model 2, the PHE and CRP are statistically 
significant in explaining health status in Malaysia at 
5 percent significance level. However, the GST is not 
significant at affecting life expectancy in Malaysia. The 
coefficient values for the PHE and CRP are small for both 
models. This is not surprising as previous studies such as 
Rajkumar and Swaroop (2008) and Filmer and Pritchett 
(1999) had also found similar results. Moreover, Filmer 
and Pritchett (1999) explained the possibility of why 
public spending on health does not have a strong effect 
on improving health status. 
Public health expenditure affects the life expectancy 
positively, while corruption has a negative effect on 
life expectancy. These results are consistent with the 
hypothesis explained earlier in the methodology section. 
A positive relationship between public health expenditure 
and life expectancy in the long run indicates the need 
for an effective government expenditure to improve the 
health status in Malaysia. On the other hand, as expected 
corruption affects life expectancy negatively. It indicates 
that high rate of corruption (bad governance) prevents the 
improvement of health status in the long run.
Table 3 reports the estimation results of the short-
run model using ARDL (1,2,2,0) and ARDL(1,2,1,0,1). In 
model 1, it can be seen that income level and corruption 
are significant at affecting health status at least at 10 
percent significant level. The error correction term which 
explains the speed of the adjustment is also significant at 1 
percent significance level for both models. This indicates 
that there is long run causality from the explanatory 
variables; GDPC, PHE, CRP and GST to life expectancy. 
In the short run, corruption also affects health status in 
Malaysia (a negative effect on life expectancy), similar 
to long run. However, public health expenditure is not 
significant in explaining life expectancy in Malaysia. It 
depicts that the government efforts in terms of expending 
money to improve health status such as investment 
or cost. In the short run, there is no ‘profit’ from the 
investment, but it is only can be obtained in the long run.
The robustness of the model is confirmed by 
several diagnostic tests such as Breusch-Godfrey serial 
correlation LM test, ARCH test, Jacque-Bera normality test, 
and Ramsey RESET specification test and this is shown 
in Table 4. All the tests reveal that the model has the 
desired econometric properties, in which it has the correct 
functional form and the model’s residuals are serially 
uncorrelated, normally distributed and homoscedastic. 
Therefore, the results reported are valid for reliable 
interpretation.
Next, we assessed the stability of the long-run 
relationship between health status and its determinants. 
We relied upon the CUSUM and CUSUM-squared tests 
proposed by Brown et al. (1975) to test for constancy of 
long-run parameters. We applied the tests to the residuals 
of the model. The CUSUM test is based on the cumulative 
sum of recursive residuals based on the first set of n 
observations. It is updated recursively and plotted against 
the break points. If the plot of the CUSUM statistics stays 
within the 5% significance level, then the estimates are 
stable. The same applies to the CUSUM-squared statistics, 
which are based on the squared recursive residuals. 
TABLE 2. Estimation of Long-Run Coefficient
Dependent variable: 
Life Expectancy
Model 1 
(1,2,2,0)
Model 2 
(1,2,1,0,1)
GDPC 0.012 
(0.003)***
0.010 
(0.007)
PHE 0.024 
(0.004)***
0.022 
(0.005)***
CRP -0.002 
(0.946)**
-0.002 
(0.001)**
GST -
0.46 
(0.165)
Constant 1.862 (0.021)
1.869 
(0.038)
Note:  The selection of optimal lags is based on the Aikaike Information 
Criterion
(*), (**) and (***) indicate significant at 1%, 5% and 10% significance 
level respectively. Numbers in parentheses are standard errors
TABLE 3. Results of Short Run ARDL Model 
Dependent variable: 
Life Expectancy
Model 1 
(1,2,2,0)
Model 2 
(1,2,1,0,1)
d(GDPC) 0.017** (0.006)
0.018** 
(0.007)
d(GDPC)t-1 0.022*** (0.006)
0.022*** 
(0.006)
d(PHE) 0.431 (0.002)
-0.103 
(0.417)
d(PHE)t-1 -0.004 (0.003) -
d(CRP) -0.001** 
(0.434)
-0.001*** 
(0.417)
d(GST) - -0.842 
(0.750)
d(Constant) 1.009** (0.1696)
0.876*** 
(0.163)
ECTt-1
-0.541*** 
(0.093)
-0.468*** 
(0.093)
Note:  The selection of optimal lags is based on the Aikaike Information 
Criterion
(*), (**) and (***) indicate significant at 1%, 5% and 10% significance 
level respectively. Numbers in parentheses are standard errors
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As can be seen in Figures 1 and 2, the plot of the CUSUM 
and CUSUM-squared statistics stay within the critical 
bounds indicating (represented by a pair of straight lines) 
the stability of the health status. They do not show any 
evidence of statistically significant breaks as indicated 
by the two statistics. 
FURTHER ANALYSIS
In this section, we further the analysis by replacing the 
variable public health expenditure (PHE) with general 
public expenditure (PE). We would like to test what are 
the effects of PE on health outcomes in Malaysia. Will it 
be consistent with the results above? Thus, in this study 
we also tested the impact of PE on health status. The 
results are reported from Table 5 to Table 8 as well as 
Figure 3 and Figure 4 respectively. From Table 5, it can 
be seen that there is only one cointegrating relationship 
among variables for model 1 and infant mortality as a 
dependent variable at least at 10 percent significance 
level. For model 2, there is no cointegrating relationship 
among variables. Thus, we proceed by using model 1 for 
the next results.
Table 6 indicates the results for model (2,2,1,1) 
using public expenditure instead of public health 
expenditure. In the long run, it can be seen that 
TABLE 4. Diagnostic Tests
LM Version F Version LM Version F Version
Test Statistics Model 1(1,2,2,0)
Model 2
(1,2,1,0,1)
aSerial Correlation 0.141 (0.707) 0.055 (0.819) 4.201 (0.040) 1.341 (0.291)
bFunctional Form 1.049 (0.306) 0.43 (0.528) 0.013 (0.909) 0.003 (0.956)
cNormality 1.526 (0.466) - 3.225 (0.199) -
dHeteroscedasticity 1.732 (0.188) 1.710 (0.205) 2.325 (0.127) 2.362 (0.139)
Note: ARDL (1,2,2,0) and (1,2,1,0,1) lag for each variable is selected based on AIC.
aLagrange multiplier test of residual serial correlation;
bRamsey’s RESET test using the square of the fitted values;
cBased on a test of skewness and kurtosis of residuals;
dBased on the regression of squared residuals on squared fitted values.
FIGURE 1. Cumulative Sum of Squares of Recursive Residuals
FIGURE 2. Cumulative Sum of Recursive Residuals
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TABLE 5. ARDL Cointegration Tests Results Using General Public Expenditure
Dependent variable Independent variable Lag F-statistic
Under 5 mortality
(Model 1)
GDPC, PHE, CRP 2
2.8032
Infant Mortality 4.2546***
Life Expectancy 3.2689
Under 5 mortality
(Model 2)
GDPC, PHE, CRP, GST 2
2.7878
Infant Mortality 2.8714  
Life Expectancy 4.1366
Note: Lower and Upper Bound Critical Values
 10% 5% 1%
 [3.008 4.150] [3.710 5.018] [5.333 7.063]
(*), (**) and (***) indicate significant at 1%, 5% and 10% significance level respectively.
TABLE 6. ARDL Results Using General Public Expenditure
Estimation of Long-Run Coefficients
Dependent variable: Model 1
Infant Mortality (2,2,1,1)
GDPC 1.076
(0.214)*
PE 0.232
(0.155)
CRP 0.102
(0.022)*
GST -
Constant 4.138(-0.311)*
Short Run ARDL Model 
d(LIM)t-1 0.755(0.129)* 
d(GDPC) 0.055(0.059)
d(GDPC)t-1 0.114(0.063)**
d(PE) -0.006(0.029)
d(CRP) 0.012(0.006)**
d(Constant) 0.887(0.332)*
ECTt-1
-0.214
(0.084)**
Diagnostic Tests 
 LM Version F Version
aSerial Correlation 0.131 [0.909] 0.005 [0.944] 
bFunctional Form 2.365 [0.124] 1.031 [0.336]
cNormality 0.477 [0.787] -
dHeteroscedasticity 0.504 [0.982] 0.460 [0.983]
Note: The selection of optimal lags is based on the Aikaike Information Criterion
(*), (**) and (***) indicate significant at 1%, 5% and 10% significance level respectively. Numbers in ( ) are estandard errors and [ ] are probability values.
Note: ARDL (1 2, 2,0) and ARDL (1,2,1,0,1) lag for each variable is selected based on AIC.
aLagrange multiplier test of residual serial correlation;
bRamsey’s RESET test using the square of the fitted values;
cBased on a test of skewness and kurtosis of residuals;
dBased on the regression of squared residuals on squared fitted values.
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corruption has a positive impact on infant mortality and 
it is significant at 1 percent significance level. It means 
that poor governance will lead to an increased mortality 
rate among babies. However, public expenditure is not 
significant at affecting infant mortality even though 
the sign is still positive, and the same result holds for 
income level. Thus, it can be said that good governance 
plays an important role to enhance health status. In the 
dynamics short run model, income level and corruption 
have a positive effect on infant mortality, while public 
health is not significant at affecting infant mortality. 
The error correction term is also significant at 5 percent 
significance level.
CONCLUSION
Although the study on the issue of government spending 
and governance has been examined extensively in 
the previous studies, less attention has been given in 
examining the impact of government expenditure and 
corruption on health outcomes and specifically through 
the utilization of time series data. Thus, this study has 
been done to extend the existing literature by providing 
new empirical evidence for the impact of government 
health expenditure and corruption on health outcomes. 
Specifically, it has been done in Malaysia. In this paper, 
the ARDL model or bound testing procedure has been 
used after considering the short annual sample size. 
The objective of this paper is to examine the long run 
relationship and the causality direction (long run and 
short run) among the variables of interest.
In this study, health status or outcome is measured 
by three indicators, namely infant mortality, under-five 
mortality and life expectancy. There are two models 
that have been estimated using the ARDL model. 
The first model is consisted of three explanatory 
variables (GDPC, PHE and CRP), while in the second 
model we added another explanatory variable namely 
government stability (GST). The main findings from 
this paper can be summarized as follows. First, there 
is a cointegration or long run relationship among 
variables both in model 1 and model 2 when the health 
status is measured by life expectancy. However, there 
is no cointegration among variables when the health 
status is measured by infant mortality and under-five 
mortality. Second, in the long and short run, both public 
health expenditure and corruption are statistically 
significant at affecting health status in Malaysia with 
the expected sign (positive). 
The findings would be of concern to Malaysian 
leaders and policy makers. Currently, the government 
has invested to provide an extensive health infrastructure 
and improve the health care system in the country. 
Besides, the Ministry of Health of Malaysia (MOH) 
has collaborated with the WHO to engage in various 
FIGURE 3. Cumulative Sum of Squares of Recursive Residuals Using General Public Expenditure
FIGURE 4. Cumulative Sum of Recursive Residuals Using General Public Expenditure
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international consultations including technical advice 
and updates in the development of health care financing 
strategies. However, new challenges have emerged 
including the changing in the disease patterns and 
population profiles as well as an increasing need for 
high-cost medical technology. As a result, the government 
has to be prepared to face new challenges in the health 
sector. It is important to ensure that Malaysians receive 
better quality of life in the long run. It includes conducting 
more consultations with other ministries and other 
stakeholders in health services in the formulation of 
new policies and implementation of certain projects. For 
instance, the cooperation between the MOH and Ministry 
of Women, Family and Community Development 
should be organized to identify the problems among 
children, women and elderly people. By doing so, the 
MOH could obtain precise information to enhance their 
projects and programmes as well as to identify the type 
of health problems. Besides, the centralisation of health 
administration could be improved by providing more 
avenues for the public both in the states and districts to 
voice out their opinions. This will help the MOH to receive 
feedback and information in improving their efficacy. 
In addition, the government of Malaysia should 
consider being more transparent to the public in terms 
of the publication of health performance indicators (in 
detail). It is very important to ensure that the public obtain 
more information and raise the awareness to enhance the 
provision of health in the country. However, increasing 
public expenditure on health is unlikely to lead to better 
outcomes if countries have poor governance. For this 
reason, the government must reduce or even eliminate 
the level of corruption as significant level of corruption 
has been proven to deter health status. 
This study is not without its limitations. First, there 
are other socioeconomic data that explain the health status 
such as female education, degree of urbanization, and 
access to safe water. We do not control these variables 
because if too many parameters are used in the model, 
it will result in the loss of degree of freedom. Therefore, 
further study should consider testing other variables that 
influence the health status in Malaysia. Moreover, other 
studies could be conducted to measure the impact of these 
socioeconomic variables on other social outcomes such 
as in the educational sector. 
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NOTES
1. The World Health Report (2000), Health System: 
improving performance.
2 Avoidable deaths are simply defined as the excess of the 
average death rate for the 0 to 5 years age group in the 
low-and middle-income countries 88 per 1000 vs. the 
level in the high-income countries, 9 per 1000 (Filmer 
and Pritchett (1999)).
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